Tryptase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 7: Line 7:


== Structural highlights ==
== Structural highlights ==
The biological assembly of Human tryptase is <scene name='46/465443/Cv/2'>homotetramer</scene> ([[2zeb]]). The <scene name='46/465443/Cv/4'>piperidine derivative TRP inhibitor interacts with both subunits of TRP</scene><ref>PMID:18272363</ref>. Water molecules shown as red spheres.  
The biological assembly of Human tryptase is <scene name='46/465443/Cv/5'>homotetramer</scene> ([[2zeb]]). The <scene name='46/465443/Cv/6'>piperidine derivative TRP inhibitor interacts with both subunits of TRP</scene><ref>PMID:18272363</ref>. Water molecules are shown as red spheres.  
</StructureSection>
</StructureSection>
== 3D Structures of tryptase ==
== 3D Structures of tryptase ==
Line 26: Line 26:
**[[2bm2]], [[2fww]] - hTRP-β2 + piperidine derivative<br />
**[[2bm2]], [[2fww]] - hTRP-β2 + piperidine derivative<br />
**[[5f03]] - hTRP-β2 + oxazolidine derivative<br />
**[[5f03]] - hTRP-β2 + oxazolidine derivative<br />
**[[4a6l]] - hTRP-α/β1 + piperidine derivative<br />
**[[4a6l]], [[6p0p]] - hTRP-α/β1 + piperidine derivative<br />
**[[4mpu]], [[4mpv]], [[4mpw]], [[4mpx]], [[4mqa]] - hTRP-α/β1 + drug<br />
**[[4mpu]], [[4mpv]], [[4mpw]], [[4mpx]], [[4mqa]] - hTRP-α/β1 + drug<br />
**[[6vvu]] - hTRP-α/1 + antibody<br />
**[[6o1f]] - hTRP-α/β1 + trypsin inhibitor + antibody<br />
**[[2fxr]] - hTRP-β2 + ketone inhibitor<br />
**[[2fxr]] - hTRP-β2 + ketone inhibitor<br />
**[[2fpz]] - hTRP-β2 + benzimidazole inhibitor<br />
**[[2fpz]] - hTRP-β2 + benzimidazole inhibitor<br />

Latest revision as of 10:07, 28 January 2024

Human tryptaseβ-2 tetramer complex with piperidine derivative inhibitor, 2zeb

Drag the structure with the mouse to rotate

3D Structures of tryptase

Updated on 28-January-2024

References

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky